New Key Statistics Module, Z-Score and F-Score
NAS:MCRB Key Ratios
Market Cap $ M | 112.16 |
Enterprise Value $ M | 196.13 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 0.75 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 126.00 |
EPS (TTM) $ | -0.90 |
Beneish M-Score | 13.17 |
10-y EBITDA Growth Rate % | -5.50 |
5-y EBITDA Growth Rate % | 10.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.95 |
EV-to-EBITDA | -2.08 |
PEG | -- |
Shares Outstanding M | 151.01 |
Net Margin (%) | -90.03 |
Operating Margin % | -85.48 |
Pre-tax Margin (%) | -90.03 |
Quick Ratio | 1.48 |
Current Ratio | 1.78 |
ROA % (ttm) | -32.46 |
ROE % (ttm) | -- |
ROIC % (ttm) | -62.68 |
Dividend Yield % | -- |
Altman Z-Score | -3.97 |
MCRB Number of Guru Trades
MCRB Volume of Guru Trades
Gurus Latest Trades with NAS:MCRB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MCRB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Seres Therapeutics Inc Insider Transactions
No Available Data
News about NAS:MCRB
Total 0- 1